Piper Sandler Weighs in on Paragon 28 Inc’s FY2021 Earnings (NYSE:FNA)

Paragon 28 Inc (NYSE:FNA) – Equities research analysts at Piper Sandler lowered their FY2021 EPS estimates for Paragon 28 in a report released on Monday, November 22nd. Piper Sandler analyst M. O’brien now anticipates that the company will earn ($0.22) per share for the year, down from their previous forecast of ($0.17). Piper Sandler has a “Overweight” rating and a $30.00 price objective on the stock. Piper Sandler also issued estimates for Paragon 28’s FY2022 earnings at ($0.19) EPS.

Paragon 28 (NYSE:FNA) last released its earnings results on Sunday, November 21st. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.08) by ($0.04).

Several other research firms have also recently commented on FNA. Needham & Company LLC began coverage on Paragon 28 in a research note on Tuesday, November 9th. They issued a “buy” rating and a $31.00 target price for the company. JMP Securities reaffirmed a “buy” rating and set a $29.00 price objective on shares of Paragon 28 in a research note on Tuesday. Finally, Canaccord Genuity started coverage on Paragon 28 in a research note on Tuesday, November 9th. They set a “buy” rating and a $28.00 price objective for the company.

NYSE FNA opened at $21.16 on Thursday. Paragon 28 has a 52 week low of $17.25 and a 52 week high of $25.41.

About Paragon 28

Paragon 28 Inc is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc is based in ENGLEWOOD, Colo.

Featured Article: How Do Mutual Funds Work?

Earnings History and Estimates for Paragon 28 (NYSE:FNA)

Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.